Fundz

PepGen Inc. Appoints Afsaneh Mohebbi as Senior Vice President, Portfolio and Program Management and Dave Borah, CFA as Senior Vice President, Investor Relations and Corporate Communications

PUBLIC · PEPGJul 02, 2024

Position

Vice President

Company

PepGen

Dave Borah
dborah@pepgen.com
BostonBiotechnologyHealthcare

Description

PepGen Inc. announced the expansion of its executive team with the appointments of Afsaneh Mohebbi, Ph.D., as Senior Vice President, Portfolio and Program Management and Dave Borah, CFA, as Senior Vice President, Investor Relations and Corporate Communications, effective immediately. These appointments are expected to enhance the company's expertise in critical areas and contribute to preparing for key clinical milestones in the second half of the year.

Quick answer

PepGen Inc. Appoints Afsaneh Mohebbi as Senior Vice President, Portfolio and Program Management and Dave Borah, CFA as Senior Vice President, Investor Relations and Corporate Communications (July 2, 2024). PepGen is based in Boston, Massachusetts, United States.

Who is the new Vice President at PepGen?
PepGen named Dave Borah Vice President, announced July 2, 2024.
What did PepGen announce on July 2, 2024?
PepGen Inc. announced the expansion of its executive team with the appointments of Afsaneh Mohebbi, Ph.D., as Senior Vice President, Portfolio and Program Management and Dave Borah, CFA, as Senior Vice President, Investor Relations and Corporate Communications, effective immediately. These appointments are expected to enhance the company's expertise in critical areas and contribute to preparing for key clinical...
What does PepGen do?
PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases.
Where is PepGen based?
PepGen is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (July 1, 2024), MBX Biosciences, Inc. (June 25, 2024), OnKure Therapeutics (June 19, 2024) and Beyond Air (June 14, 2024) also announced leadership changes within 45 days of PepGen.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at PepGen, and when

A new leader at PepGen brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day PepGen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PepGen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PepGen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PepGen

Location

Boston, Massachusetts, United States

About

PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide (EDO) platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PepGen changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mary
Likely contact at this company
••••••••@••••••••

See Mary's verified email →

Afsaneh
Likely contact at this company
••••••••@••••••••

See Afsaneh's verified email →

Paul
Likely contact at this company
••••••••@••••••••

See Paul's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for PepGen's next move

Learn about Strategic plan

PepGen changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.